| Author | Dorst, Johannes | dc.contributor.author |
| Author | Genge, Angela | dc.contributor.author |
| Date of accession | 2022-10-07T07:48:30Z | dc.date.accessioned |
| Available in OPARU since | 2022-10-07T07:48:30Z | dc.date.available |
| Date of first publication | 2022 | dc.date.issued |
| Language | en | dc.language.iso |
| Publisher | Universität Ulm | dc.publisher |
| Keyword | amyotrophic lateral sclerosis | dc.subject |
| Keyword | clinical studies | dc.subject |
| Keyword | edaravone | dc.subject |
| Keyword | sodium phenylbutyrate-taurusodiol | dc.subject |
| Keyword | tofersen | dc.subject |
| Keyword | DOUBLE-BLIND | dc.subject |
| Keyword | SODIUM PHENYLBUTYRATE | dc.subject |
| Keyword | RASAGILINE | dc.subject |
| Keyword | RILUZOLE | dc.subject |
| Keyword | PHASE-2 | dc.subject |
| Keyword | TRIAL | dc.subject |
| Keyword | SOD1 | dc.subject |
| Keyword | DEGENERATION | dc.subject |
| Keyword | SURVIVAL | dc.subject |
| Dewey Decimal Group | DDC 610 / Medicine & health | dc.subject.ddc |
| Title | Clinical studies in amyotrophic lateral sclerosis | dc.title |
| Resource type | Wissenschaftlicher Artikel | dc.type |
| Institution | UKU. Klinik für Neurologie | uulm.affiliationSpecific |
| DCMI Type | Text | uulm.typeDCMI |
| Category | Publikationsnachweise | uulm.category |
| DOI (external) | 10.1097/WCO.0000000000001099 | dc.identifier.doiExternal |
| Source - Title of source | Current Opinion in Neurology | source.title |
| Source - Place of publication | Lippincott, Williams & Wilkins | source.publisher |
| Source - Volume | 35 | source.volume |
| Source - Issue | 5 | source.issue |
| Source - Year | 2022 | source.year |
| Source - From page | 686 | source.fromPage |
| Source - To page | 692 | source.toPage |
| Source - ISSN | 1350-7540 | source.identifier.issn |
| Source - eISSN | 1473-6551 | source.identifier.eissn |
| Community | Universität Ulm / Medizin | uulm.community |
| WoS | 000850526900020 | uulm.identifier.wos |
| Bibliography | uulm | uulm.bibliographie |
